Applications of Tissue Microarray Technology

  • Ronald SimonEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 664)


Tissue microarrays (TMAs) have become a standard tool for tissue-based research during the last decade. In cancer research, depending on the available data attached to the arrayed tissue, three main types of arrays are commonly manufactured. Prevalence TMAs have no further data available and are suited to estimate the frequency of the occurrence of a particular alteration. Progression arrays include tissues of different stages of disease, and are instrumental to study the role of a marker protein for tumor initiation, progression, or metastatic growth. Prognosis TMAs contain tissues with patient follow-up data. These TMAs are the key to uncover the clinical impact of molecular markers. In combination with normal tissue arrays representing healthy tissues, prevalence, progression, and prognosis TMAs allow for a rapid and comprehensive analysis of molecular markers in human cancers. TMAs are also successfully used for many noncancer applications, such as Alzheimer’s or inflammatory disease research.

Key words

Tissue microarray Prevalence array Progression array Prognosis array Cross reactivity testing Translational research 


  1. 1.
    Belin, D. (1998) The use of RNA probes for the analysis of gene expression. Northern blot hybridization and ribonuclease protection assay. Methods Mol Biol; 86:87–102.PubMedGoogle Scholar
  2. 2.
    Bichsel, V. E., Liotta, L. A. and Petricoin, E. F., 3rd (2001) Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J; 1:69–78.Google Scholar
  3. 3.
    Kallioniemi, O. P. (2001) Biochip technologies in cancer research. Ann Med; 2:142–7.CrossRefGoogle Scholar
  4. 4.
    Walker, N. J. (2001) Real-time and quantitative PCR: applications to mechanism-based toxicology. J Biochem Mol Toxicol; 3:121–7.CrossRefGoogle Scholar
  5. 5.
    Andersen, C. L., Monni, O., Wagner, U., Kononen, J., Barlund, M., Bucher, C., Haas, P., Nocito, A., Bissig, H., Sauter, G. and Kallioniemi, A. (2002) High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol; 1:73–9.CrossRefGoogle Scholar
  6. 6.
    Schraml, P., Bucher, C., Bissig, H., Nocito, A., Haas, P., Wilber, K., Seelig, S., Kononen, J., Mihatsch, M. J., Dirnhofer, S. and Sauter, G. (2003) Cyclin E overexpression and amplification in human tumours. J Pathol; 3:375–82.CrossRefGoogle Scholar
  7. 7.
    Gravalos, C. and Jimeno, A. (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol; 9:1523–9.CrossRefGoogle Scholar
  8. 8.
    Tapia, C., Glatz, K., Novotny, H., Lugli, A., Horcic, M., Seemayer, C. A., Tornillo, L., Terracciano, L., Spichtin, H., Mirlacher, M., Simon, R. and Sauter, G. (2007) Close association between HER-2 amplification and overexpression in human tumors of non-breast origin. Mod Pathol; 2:192–8.CrossRefGoogle Scholar
  9. 9.
    Almanzar, G., Olkhanud, P. B., Bodogai, M., Dell’agnola, C., Baatar, D., Hewitt, S. M., Ghimenton, C., Tummala, M. K., Weeraratna, A. T., Hoek, K. S., Kouprina, N., Larionov, V. and Biragyn, A. (2009) Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clin Cancer Res; 6:1954–63.CrossRefGoogle Scholar
  10. 10.
    Erez, A., Perelman, M., Hewitt, S. M., Cojacaru, G., Goldberg, I., Shahar, I., Yaron, P., Muler, I., Campaner, S., Amariglio, N., Rechavi, G., Kirsch, I. R., Krupsky, M., Kaminski, N. and Izraeli, S. (2004) Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene; 31:5371–7.CrossRefGoogle Scholar
  11. 11.
    Geiszt, M., Lekstrom, K., Brenner, S., Hewitt, S. M., Dana, R., Malech, H. L. and Leto, T. L. (2003) NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol; 1:299–306.Google Scholar
  12. 12.
    Dicken, B. J., Graham, K., Hamilton, S. M., Andrews, S., Lai, R., Listgarten, J., Jhangri, G. S., Saunders, L. D., Damaraju, S. and Cass, C. (2006) Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg; 1:64–73.CrossRefGoogle Scholar
  13. 13.
    Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G. and Kallioniemi, O. P. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med; 7:844–7.CrossRefGoogle Scholar
  14. 14.
    Bubendorf, L., Kolmer, M., Kononen, J., Koivisto, P., Mousses, S., Chen, Y., Mahlamaki, E., Schraml, P., Moch, H., Willi, N., Elkahloun, A. G., Pretlow, T. G., Gasser, T. C., Mihatsch, M. J., Sauter, G. and Kallioniemi, O. P. (1999) Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst; 20:1758–64.CrossRefGoogle Scholar
  15. 15.
    Bubendorf, L., Kononen, J., Koivisto, P., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G. and Kallioniemi, O.-P. (1999) Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays. Cancer Res; 4:803–6.Google Scholar
  16. 16.
    Richter, J., Wagner, U., Kononen, J., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Wilber, K., Anabitarte, M., Hering, F., Hardmeier, T., Schonenberger, A., Flury, R., Jager, P., Fehr, J. L., Schraml, P., Moch, H., Mihatsch, M. J., Gasser, T., Kallioniemi, O. P. and Sauter, G. (2000) High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol; 3:787–94.CrossRefGoogle Scholar
  17. 17.
    Simon, R., Nocito, A., Hubscher, T., Bucher, C., Torhorst, J., Schraml, P., Bubendorf, L., Mihatsch, M. M., Moch, H., Wilber, K., Schotzau, A., Kononen, J. and Sauter, G. (2001) Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst; 15:1141–6.CrossRefGoogle Scholar
  18. 18.
    Simon, R., Richter, J., Wagner, U., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Wilber, K., Anabitarte, M., Hering, F., Hardmeier, T., Schonenberger, A., Flury, R., Jager, P., Fehr, J. L., Schraml, P., Moch, H., Mihatsch, M. J., Gasser, T. and Sauter, G. (2001) High-throughout tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res; 11:4514–9.Google Scholar
  19. 19.
    Simon, R., Struckmann, K., Schraml, P., Wagner, U., Forster, T., Moch, H., Fijan, A., Bruderer, J., Wilber, K., Mihatsch, M. J., Gasser, T. and Sauter, G. (2002) Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene; 16:2476–83.CrossRefGoogle Scholar
  20. 20.
    Kocher, T., Zheng, M., Bolli, M., Simon, R., Forster, T., Schultz-Thater, E., Remmel, E., Noppen, C., Schmid, U., Ackermann, D., Mihatsch, M. J., Gasser, T., Heberer, M., Sauter, G. and Spagnoli, G. C. (2002) Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer; 6:702–5.CrossRefGoogle Scholar
  21. 21.
    Park, S. Y., Kim, H. S., Hong, E. K. and Kim, W. H. (2002) Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol; 11:1078–85.CrossRefGoogle Scholar
  22. 22.
    Saramaki, O., Willi, N., Bratt, O., Gasser, T. C., Koivisto, P., Nupponen, N. N., Bubendorf, L. and Visakorpi, T. (2001) Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am J Pathol; 6:2089–94.CrossRefGoogle Scholar
  23. 23.
    Skacel, M., Ormsby, A. H., Pettay, J. D., Tsiftsakis, E. K., Liou, L. S., Klein, E. A., Levin, H. S., Zippe, C. D. and Tubbs, R. R. (2001) Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Hum Pathol; 12:1392–7.CrossRefGoogle Scholar
  24. 24.
    Rubin, M. A., Mucci, N. R., Figurski, J., Fecko, A., Pienta, K. J. and Day, M. L. (2001) E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol; 7:690–7.CrossRefGoogle Scholar
  25. 25.
    Fuller, C. E., Wang, H., Zhang, W., Fuller, G. N. and Perry, A. (2002) High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol; 12:1078–84.Google Scholar
  26. 26.
    Li, B., Tsao, S. W., Li, Y. Y., Wang, X., Ling, M. T., Wong, Y. C., He, Q. Y. and Cheung, A. L. (2009) Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer; 125(11):2576–85.PubMedCrossRefGoogle Scholar
  27. 27.
    Christgen, M., Christgen, H., Heil, C., Krech, T., Langer, F., Kreipe, H. and Lehmann, U. (2009) Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer. Cancer Sci; 100(9):1767–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Rushing, E. J., Sandberg, G. D. and Horkayne-Szakaly, I. (2009) High-grade astrocytomas show increased nestin and Wilms’s tumor gene (WT1) protein expression. Int J Surg Pathol.Google Scholar
  29. 29.
    Oka, T., Yoshino, T., Hayashi, K., Ohara, N., Nakanishi, T., Yamaai, Y., Hiraki, A., Sogawa, C. A., Kondo, E., Teramoto, N., Takahashi, K., Tsuchiyama, J. and Akagi, T. (2001) Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray. Am J Pathol; 4:1495–505.CrossRefGoogle Scholar
  30. 30.
    Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Kochli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., Kallioniemi, O. P. and Sauter, G. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol; 6:2249–56.CrossRefGoogle Scholar
  31. 31.
    Barlund, M., Forozan, F., Kononen, J., Bubendorf, L., Chen, Y., Bittner, M. L., Torhorst, J., Haas, P., Bucher, C., Sauter, G., Kallioniemi, O. P. and Kallioniemi, A. (2000) Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst; 15:1252–9.CrossRefGoogle Scholar
  32. 32.
    Moch, H., Schraml, P., Bubendorf, L., Mirlacher, M., Kononen, J., Gasser, T., Mihatsch, M. J., Kallioniemi, O. P. and Sauter, G. (1999) High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol; 4:981–6.CrossRefGoogle Scholar
  33. 33.
    Nocito, A., Bubendorf, L., Tinner, E. M., Suess, K., Wagner, U., Forster, T., Kononen, J., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Anabitarte, M., Hering, F., Hardmeier, T., Schoenenberger, A. J., Flury, R., Jager, P., Fehr, J. L., Schraml, P., Moch, H., Mihatsch, M. J., Gasser, T. and Sauter, G. (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol; 3:349–57.CrossRefGoogle Scholar
  34. 34.
    Hoos, A., Stojadinovic, A., Mastorides, S., Urist, M. J., Polsky, D., Di Como, C. J., Brennan, M. F. and Cordon-Cardo, C. (2001) High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer; 4:869–74.CrossRefGoogle Scholar
  35. 35.
    Hoos, A., Stojadinovic, A., Singh, B., Dudas, M. E., Leung, D. H., Shaha, A. R., Shah, J. P., Brennan, M. F., Cordon-Cardo, C. and Ghossein, R. (2002) Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol; 1:175–83.CrossRefGoogle Scholar
  36. 36.
    Simon, R., Atefy, R., Wagner, U., Forster, T., Fijan, A., Bruderer, J., Wilber, K., Mihatsch, M. J., Gasser, T. and Sauter, G. (2003) HER-2 and TOP2A coamplification in urinary bladder cancer. Int J Cancer; 5:764–72.CrossRefGoogle Scholar
  37. 37.
    Oeggerli, M., Tomovska, S., Schraml, P., Calvano-Forte, D., Schafroth, S., Simon, R., Gasser, T., Mihatsch, M. J. and Sauter, G. (2004) E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene; 33:5616–23.CrossRefGoogle Scholar
  38. 38.
    Ginestier, C., Charafe-Jauffret, E., Bertucci, F., Eisinger, F., Geneix, J., Bechlian, D., Conte, N., Adelaide, J., Toiron, Y., Nguyen, C., Viens, P., Mozziconacci, M. J., Houlgatte, R., Birnbaum, D. and Jacquemier, J. (2002) Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol; 4:1223–33.CrossRefGoogle Scholar
  39. 39.
    Poremba, C., Heine, B., Diallo, R., Heinecke, A., Wai, D., Schaefer, K. L., Braun, Y., Schuck, A., Lanvers, C., Bankfalvi, A., Kneif, S., Torhorst, J., Zuber, M., Kochli, O. R., Mross, F., Dieterich, H., Sauter, G., Stein, H., Fogt, F. and Boecker, W. (2002) Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol; 2:181–9.CrossRefGoogle Scholar
  40. 40.
    Ristimaki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., Joensuu, H. and Isola, J. (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res; 3:632–5.Google Scholar
  41. 41.
    Al-Kuraya, K., Schraml, P., Torhorst, J., Tapia, C., Zaharieva, B., Novotny, H., Spichtin, H., Maurer, R., Mirlacher, M., Kochli, O., Zuber, M., Dieterich, H., Mross, F., Wilber, K., Simon, R. and Sauter, G. (2004) Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res; 23:8534–40.CrossRefGoogle Scholar
  42. 42.
    Holst, F., Stahl, P. R., Ruiz, C., Hellwinkel, O., Jehan, Z., Wendland, M., Lebeau, A., Terracciano, L., Al-Kuraya, K., Janicke, F., Sauter, G. and Simon, R. (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nature Genetics; 5:655–60.CrossRefGoogle Scholar
  43. 43.
    Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A. and Chinnaiyan, A. M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature; 6849:822–6.CrossRefGoogle Scholar
  44. 44.
    Mousses, S., Bubendorf, L., Wagner, U., Hostetter, G., Kononen, J., Cornelison, R., Goldberger, N., Elkahloun, A. G., Willi, N., Koivisto, P., Ferhle, W., Raffeld, M., Sauter, G. and Kallioniemi, O. P. (2002) Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res; 5:1256–60.Google Scholar
  45. 45.
    Fleischmann, A., Schlomm, T., Huland, H., Kollermann, J., Simon, P., Mirlacher, M., Salomon, G., Chun, F. H., Steuber, T., Simon, R., Sauter, G., Graefen, M. and Erbersdobler, A. (2008) Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients. Clin Cancer Res; 23:7838–42.CrossRefGoogle Scholar
  46. 46.
    Schlomm, T., Iwers, L., Kirstein, P., Jessen, B., Kollermann, J., Minner, S., Passow-Drolet, A., Mirlacher, M., Milde-Langosch, K., Graefen, M., Haese, A., Steuber, T., Simon, R., Huland, H., Sauter, G. and Erbersdobler, A. (2008) Clinical significance of p53 alterations in surgically treated prostate cancers. Mod Pathol; 21(11):1371–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Fleischmann, A., Schlomm, T., Kollermann, J., Sekulic, N., Huland, H., Mirlacher, M., Sauter, G., Simon, R. and Erbersdobler, A. (2009) Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate; 69(9):976–81.PubMedCrossRefGoogle Scholar
  48. 48.
    Miettinen, H. E., Jarvinen, T. A., Kellner, U., Kauraniemi, P., Parwaresch, R., Rantala, I., Kalimo, H., Paljarvi, L., Isola, J. and Haapasalo, H. (2000) High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathol Appl Neurobiol; 6:504–12.CrossRefGoogle Scholar
  49. 49.
    Sallinen, S. L., Sallinen, P. K., Haapasalo, H. K., Helin, H. J., Helen, P. T., Schraml, P., Kallioniemi, O. P. and Kononen, J. (2000) Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res; 23:6617–22.Google Scholar
  50. 50.
    Miettinen, H. E., Paunu, N., Rantala, I., Kalimo, H., Paljarvi, L., Helin, H. and Haapasalo, H. (2001) Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique. J Neurooncol; 1:29–37.CrossRefGoogle Scholar
  51. 51.
    Wang, Y., Wu, M. C., Sham, J. S., Zhang, W., Wu, W. Q. and Guan, X. Y. (2002) Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer; 11:2346–52.CrossRefGoogle Scholar
  52. 52.
    Brannan, J. M., Dong, W., Prudkin, L., Behrens, C., Lotan, R., Bekele, B. N., Wistuba, I. and Johnson, F. M. (2009) Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer. Clin Cancer Res; 13:4423–30.CrossRefGoogle Scholar
  53. 53.
    Li, R., Erdamar, S., Dai, H., Sayeeduddin, M., Frolov, A., Wheeler, T. M. and Ayala, G. E. (2009) Cytoplasmic accumulation of glycogen synthase kinase-3beta is associated with aggressive clinicopathological features in human prostate cancer. Anticancer Res; 6:2077–81.Google Scholar
  54. 54.
    McSherry, E. A., McGee, S. F., Jirstrom, K., Doyle, E. M., Brennan, D. J., Landberg, G., Dervan, P. A., Hopkins, A. M. and Gallagher, W. M. (2009) JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer; 6:1343–51.CrossRefGoogle Scholar
  55. 55.
    Chung, G. G., Provost, E., Kielhorn, E. P., Charette, L. A., Smith, B. L. and Rimm, D. L. (2001) Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res; 12:4013–20.Google Scholar
  56. 56.
    Otsuka, M., Kato, M., Yoshikawa, T., Chen, H., Brown, E. J., Masuho, Y., Omata, M. and Seki, N. (2001) Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun; 4:876–81.CrossRefGoogle Scholar
  57. 57.
    Hoos, A., Nissan, A., Stojadinovic, A., Shia, J., Hedvat, C. V., Leung, D. H., Paty, P. B., Klimstra, D., Cordon-Cardo, C. and Wong, W. D. (2002) Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin Cancer Res; 12:3841–9.Google Scholar
  58. 58.
    Garcia, J. F., Camacho, F. I., Morente, M., Fraga, M., Montalban, C., Alvaro, T., Bellas, C., Castano, A., Diez, A., Flores, T., Martin, C., Martinez, M. A., Mazorra, F., Menarguez, J., Mestre, M. J., Mollejo, M., Saez, A. I., Sanchez, L. and Piris, M. A. (2003) Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood; 2:681–9.CrossRefGoogle Scholar
  59. 59.
    Kielhorn, E., Provost, E., Olsen, D., D’Aquila, T. G., Smith, B. L., Camp, R. L. and Rimm, D. L. (2003) Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer; 5:652–6.CrossRefGoogle Scholar
  60. 60.
    Press, M. F., Sauter, G., Bernstein, L., Villalobos, I. E., Mirlacher, M., Zhou, J. Y., Wardeh, R., Li, Y. T., Guzman, R., Ma, Y., Sullivan-Halley, J., Santiago, A., Park, J. M., Riva, A. and Slamon, D. J. (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res; 18:6598–607.CrossRefGoogle Scholar
  61. 61.
    Datta, M. W., Kahler, A., Macias, V., Brodzeller, T. and Kajdacsy-Balla, A. (2005) A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens: examples with prostate cancer. Appl Immunohistochem Mol Morphol; 1:96–103.CrossRefGoogle Scholar
  62. 62.
    Obermann, E. C., Marienhagen, J., Stoehr, R., Wuensch, P. H. and Hofstaedter, F. (2005) Tissue microarray construction from bone marrow biopsies. Biotechniques; 39(6):822, 4, 6.Google Scholar
  63. 63.
    Jhavar, S., Bartlett, J., Kovacs, G., Corbishley, C., Dearnaley, D., Eeles, R., Khoo, V., Huddart, R., Horwich, A., Thompson, A., Norman, A., Brewer, D., Cooper, C. S. and Parker, C. (2009) Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer Prostatic Dis; 2:143–7.CrossRefGoogle Scholar
  64. 64.
    Hoos, A. and Cordon-Cardo, C. (2001) Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest; 10:1331–8.CrossRefGoogle Scholar
  65. 65.
    Kellner, A., Matschke, J., Bernreuther, C., Moch, H., Ferrer, I. and Glatzel, M. (2009) Autoantibodies against beta-amyloid are common in Alzheimer’s disease and help control plaque burden. Ann Neurol; 1:24–31.CrossRefGoogle Scholar
  66. 66.
    Mengel, M., von Wasielewski, R., Wiese, B., Rudiger, T., Muller-Hermelink, H. K. and Kreipe, H. (2002) Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol; 3:292–9.CrossRefGoogle Scholar
  67. 67.
    von Wasielewski, R., Mengel, M., Wiese, B., Rudiger, T., Muller-Hermelink, H. K. and Kreipe, H. (2002) Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol; 5:675–82.Google Scholar
  68. 68.
    Packeisen, J., Buerger, H., Krech, R. and Boecker, W. (2002) Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol; 8:613–5.CrossRefGoogle Scholar
  69. 69.
    Sauter, G. and Mirlacher, M. (2002) Tissue microarrays for predictive molecular pathology. J Clin Pathol; 8:575–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Institute of PathologyUniversity Medical Center Hamburg EppendorfHamburgGermany

Personalised recommendations